Innate Immunity and Biomaterials at the Nexus: Friends or Foes

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Christo, Susan N ^a   Diener, Kerrilyn R ^a,b   Bachhuka, Akash ^a   Vasilev, Krasimir ^a   Hayball, John D ^a,c  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CRYOPYRIN; INFLAMMASOME; INTEGRIN RECEPTOR; PATTERN RECOGNITION RECEPTOR; SELF ASSEMBLED MONOLAYER; TOLL LIKE RECEPTOR;

BIOCOMPATIBILITY; CELL ENCAPSULATION; CELL MEMBRANE; CELL WALL; CHRONIC INFLAMMATION; CLINICAL FEATURE; DISEASE ASSOCIATION; FOREIGN BODY; FOREIGN BODY REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; IMPLANTATION; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN BINDING; REGULATORY MECHANISM; REVIEW; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; SURFACE PROPERTY; TIGHT JUNCTION; VASCULARIZATION; ADVERSE EFFECTS; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECTS; FOREIGN-BODY REACTION; IMMUNOLOGY; PROSTHESES AND ORTHOSES;

ANIMALIA;

ANIMALS; BIOCOMPATIBLE MATERIALS; FOREIGN-BODY REACTION; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; PROSTHESES AND IMPLANTS;

EID: 84938118329     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/342304     Document Type: Review

References (345)

1. A. H. Morris and T. R. Kyriakides, "Matricellular proteins and biomaterials, " Matrix Biology, vol. 37, pp. 183-191, 2014.
2. P. Agrawal, S. Soni, G. Mittal, and A. Bhatnagar, "Role of polymeric biomaterials as wound healing agents, " The International Journal of Lower Extremity Wounds, vol. 13, no. 3, pp. 180-190, 2014.
3. O. Peralta, S. Diaz, and H. Croxatto, "Subdermal contraceptive implants, " The Journal of Steroid Biochemistry and Molecular Biology, vol. 53, no. 1-6, pp. 223-226, 1995.
4. A.M. Teunissen, B. Grimm, and F. J.M. E. Roumen, "Continuation rates of the subdermal contraceptive Implanon and associated influencing factors, "The European Journal of Contraception & Reproductive Health Care, vol. 19, no. 1, pp. 15-21, 2014.
5. L. D. Ireland, V. Goyal, C. A. Raker, A. Murray, and R. H. Allen, "The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding, " Contraception, vol. 90, no. 3, pp. 253-258, 2014.
6. I. Babiak, "Open tibial fractures grade IIIC treated successfully with external fixation, negative-pressure wound therapy and recombinant human bone morphogenetic protein 7, " InternationalWound Journal, vol. 11, no. 5, pp. 476-482, 2014.
7. E. Bar-On, T. Becker, K. Katz, S. Velkes, M. Salai, and D. M. Weigl, "Corrective lower limb osteotomies in children using temporary external fixation and percutaneous locking plates, " Journal of Children'sOrthopaedics, vol. 3, no.2, pp. 137-143, 2009.
8. G. G. Zafiropoulos, O. Hoffmann, and G. Deli, "A method for fabrication of implant-supported fixed partial dentures, " The Journal of Oral Implantology, vol. 40, no. 3, pp. 271-279, 2014.
9. V. Wiegering, S. Schmid, O. Andres et al., "Thrombosis as a complication of central venous access in pediatric patients with malignancies: a 5-year single-center experience, " BMC Hematology, vol. 14, no. 1, p. 18, 2014.
10. S. H. Han and J. H. Lee, "Colonic stent-related complications and their management, " Clinical Endoscopy, vol. 47, no. 5, pp. 415-419, 2014.
11. T. H. Park, S. W. Seo, J.-K. Kim, and C. H. Chang, "Clinical experience with polymethylmethacrylate microsphere filler complications, " Aesthetic Plastic Surgery, vol. 36, no. 2, pp. 421-426, 2012.
12. K. C. Smith, "Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations, " Dermatology Online Journal, vol. 14, no. 8, article 3, 2008.
13. J. Charnley, "Anchorage of the femoral head prosthesis to the shaft of the femur, " The Journal of Bone and Joint Surgery- British Volume, vol. 42, pp. 28-30, 1960.
14. M. Marcolongo, P. Ducheyne, J. Garino, and E. Schepers, "Bioactive glass fiber/polymeric composites bond to bone tissue, " Journal of Biomedical Materials Research, vol. 39, no. 1, pp. 161-170, 1997.
15. W. Höland, M. Schweiger, R. Watzke, A. Peschke, and H. Kappert, "Ceramics as biomaterials for dental restoration, " Expert Review of Medical Devices, vol. 5, no. 6, pp. 729-745, 2008.
16. P. Kosyfaki and M. V. Swain, "Adhesion determination of dental porcelain to zirconia using the Schwickerath test: strength vs. fracture energy approach, " Acta Biomaterialia, vol. 10, no. 11, pp. 4861-4869, 2014.
17. G. Lorenzoni, F. Folino, N. Soriani, S. Iliceto, and D. Gregori, "Cost-effectiveness of early detection of atrial fibrillation via remote control of implanted devices, " Journal of Evaluation in Clinical Practice, vol. 20, no. 5, pp. 570-577, 2014.
18. M. E. McIvor, J. Reddinger, E. Floden et al., "Study of pacemaker and implantable cardioverter defibrillator triggering by electronic article surveillance devices (SPICED TEAS), " Pacing andClinical Electrophysiology, vol. 21, no. 10, pp. 1847-1861, 1998.
19. R. Gifford, M. M. Batchelor, Y. Lee, G. Gokulrangan, M. E. Meyerhoff, and G. S. Wilson, "Mediation of in vivo glucose sensor inflammatory response via nitric oxide release, " Journal of Biomedical Materials Research Part A, vol. 75, no. 4, pp. 755-766, 2005.
20. P. A. Palod, S. S. Pandey, S. Hayase, and V. Singh, "Templateassisted electrochemical growth of polypyrrole nanotubes for development of high sensitivity glucose biosensor, " Applied Biochemistry and Biotechnology, vol. 174, no. 3, pp. 1059-1072, 2014.
21. N. N. Le, M. B. Rose, H. Levinson, and B. Klitzman, "Implant healing in experimental animal models of diabetes, " Journal of Diabetes Science and Technology, vol. 5, no. 3, pp. 605-618, 2011.
22. S. Franz, S. Rammelt, D. Scharnweber, and J. C. Simon, "Immune responses to implants-a review of the implications for the design of immunomodulatory biomaterials, " Biomaterials, vol. 32, no. 28, pp. 6692-6709, 2011.
23. S.K. Chuang, L. J. Wei, C.W. Douglass, and T. B. Dodson, "Risk factors for dental implant failure: a strategy for the analysis of clustered failure-time observations, " Journal of Dental Research, vol. 81, no. 8, pp. 572-577, 2002.
24. B. R. Chrcanovic, T. Albrektsson, and A. Wennerberg, "Reasons for failures of oral implants, " Journal of Oral Rehabilitation, vol. 41, no. 6, pp. 443-476, 2014.
25. B. R. Chrcanovic, T. Albrektsson, and A. Wennerberg, "Periodontally compromised vs. periodontally healthy patients and dental implants: a systematic review andmeta-analysis, " Journal of Dentistry, vol. 42, no. 12, pp. 1509-1527, 2014.
26. J. M. Anderson, "Inflammatory response to implants, " ASAIO Transactions, vol. 34, no. 2, pp. 101-107, 1988.
27. B. N. Brown and S. F. Badylak, "Expanded applications, shifting paradigms and an improved understanding of host-biomaterial interactions, " Acta Biomaterialia, vol. 9, no. 2, pp. 4948-4955, 2013.
28. F. Boccafoschi, C. Mosca, and M. Cannas, "Cardiovascular biomaterials: when the inflammatory response helps to efficiently restore tissue functionality?" Journal of Tissue Engineering and Regenerative Medicine, vol. 8, no. 4, pp. 253-267, 2014.
29. W. K. Ward, "A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis, " Journal of Diabetes Science and Technology, vol. 2, no. 5, pp. 768-777, 2008.
30. J. M. Anderson, A. Rodriguez, and D. T. Chang, "Foreign body reaction to biomaterials, " Seminars in Immunology, vol. 20, no. 2, pp. 86-100, 2008.
31. R. E. Baier and R. C. Dutton, "Initial events in interactions of blood with a foreign surface, " Journal of Biomedical Materials Research, vol. 3, no. 1, pp. 191-206, 1969.
32. L. Vroman, A. L. Adams, G. C. Fischer, and P. C. Munoz, "Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces, " Blood, vol. 55, no. 1, pp. 156-159, 1980.
33. C. J. Wilson, R. E. Clegg, D. I. Leavesley, and M. J. Pearcy, "Mediation of biomaterial-cell interactions by adsorbed proteins: a review, " Tissue Engineering, vol. 11, no. 1-2, pp. 1-18, 2005.
34. G. Nimeri, B. Lassen, C. G.Gölander, U. Nilsson, and H. Elwing, "Adsorption of fibrinogen and some other proteins from blood plasma at a variety of solid surfaces, " Journal of Biomaterials Science. Polymer Edition, vol. 6, no. 6, pp. 573-583, 1994.
35. C. J. Nonckreman, S. Fleith, P. G. Rouxhet, and C. C. Dupont- Gillain, "Competitive adsorption of fibrinogen and albumin and blood platelet adhesion on surfaces modifiedwith nanoparticles and/or PEO, "Colloids and Surfaces B: Biointerfaces, vol. 77, no. 2, pp. 139-149, 2010.
36. D. J. Fabrizius-Homan and S. L. Cooper, "Competitive adsorption of vitronectin with albumin, fibrinogen, and fibronectin on polymeric biomaterials, " Journal of Biomedical Materials Research, vol. 25, no. 8, pp. 953-971, 1991.
37. D. J. Fabrizius-Homan and S. L. Cooper, "A comparison of the adsorption of three adhesive proteins to biomaterial surfaces, " Journal of Biomaterials Science. Polymer Edition, vol. 3, no. 1, pp. 27-47, 1991.
38. M. B. Gorbet and M. V. Sefton, "Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes, " Biomaterials, vol. 25, no. 26, pp. 5681-5703, 2004.
39. K. N. Ekdahl, J. D. Lambris, H. Elwing et al., "Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies, " Advanced Drug Delivery Reviews, vol. 63, no. 12, pp. 1042-1050, 2011.
40. B. Nilsson, K.N. Ekdahl, T. E. Mollnes, and J.D. Lambris, "The role of complement in biomaterial-induced inflammation, " Molecular Immunology, vol. 44, no. 1-3, pp. 82-94, 2007.
41. J. Andersson, K. N. Ekdahl, J. D. Lambris, and B. Nilsson, "Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface, " Biomaterials, vol. 26, no. 13, pp. 1477-1485, 2005.
42. B. Engelmann and S. Massberg, "Thrombosis as an intravascular effector of innate immunity, " Nature Reviews Immunology, vol. 13, no. 1, pp. 34-45, 2013.
43. Y. Wu, F. I. Simonovsky, B. D. Ratner, and T. A. Horbett, "The role of adsorbed fibrinogen in platelet adhesion to polyurethane surfaces: a comparison of surface hydrophobicity, protein adsorption, monoclonal antibody binding, and platelet adhesion, " Journal of Biomedical Materials Research Part A, vol. 74, no. 4, pp. 722-738, 2005.
44. A. Chiumiento, S. Lamponi, and R. Barbucci, "Role of fibrinogen conformation in platelet activation, " Biomacromolecules, vol. 8, no. 2, pp. 523-531, 2007.
45. F. M. Szaba and S. T. Smiley, "Roles for thrombin and fibrin( ogen) in cytokine/chemokine production and macrophage adhesion in vivo, " Blood, vol. 99, no. 3, pp. 1053-1059, 2002.
46. M. J. Flick, X. Du, D. P. Witte et al., "Leukocyte engagement of fibrin(ogen) via the integrin receptor αMβ2/Mac-1 is critical for host inflammatory response in vivo, "The Journal of Clinical Investigation, vol. 113, no. 11, pp. 1596-1606, 2004.
47. A. K. McNally, J. A. Jones, S. R. MacEwan, E. Colton, and J. M. Anderson, "Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation, " Journal of Biomedical Materials Research-Part A, vol. 86, no. 2, pp. 535-543, 2008.
48. C. R. Jenney and J. M. Anderson, "Adsorbed serum proteins responsible for surface dependent human macrophage behavior, " Journal of Biomedical Materials Research, vol. 49, no. 4, pp. 435-447, 2000.
49. T. Groth, I. Zlatanov, and G. Altankov, "Adhesion of human peripheral lymphocytes on biomaterials preadsorbed with fibronectin and vitronectin, " Journal of Biomaterials Science. Polymer Edition, vol. 6, no. 8, pp. 729-739, 1994.
50. B. G. Keselowsky, A. W. Bridges, K. L. Burns et al., "Role of plasma fibronectin in the foreign body response to biomaterials, " Biomaterials, vol. 28, no. 25, pp. 3626-3631, 2007.
51. M. Shen, I. Garcia, R. V. Maier, and T. A. Horbett, "Effects of adsorbed proteins and surface chemistry on foreign body giant cell formation, tumor necrosis factor alpha release and procoagulant activity of monocytes, " Journal of Biomedical Materials Research-Part A, vol. 70, no. 4, pp. 533-541, 2004.
52. A. Zarbock, R. K. Polanowska-Grabowska, and K. Ley, "Plateletneutrophil- interactions: linking hemostasis and inflammation, " Blood Reviews, vol. 21, no. 2, pp. 99-111, 2007.
53. A. Hidalgo, J. Chang, J.-E. Jang, A. J. Peired, E. Y. Chiang, and P. S. Frenette, "Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury, " Nature Medicine, vol. 15, no. 4, pp. 384-391, 2009.
54. T.G. Diacovo, S. J. Roth, J.M. Buccola, D. F. Bainton, and T.A. Springer, "Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of Pselectin and the β2- integrin CD11b/CD18, " Blood, vol. 88, no. 1, pp. 146-157, 1996.
55. T. Palabrica, R. Lobb, B.C. Furie et al., "Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets, " Nature, vol. 359, no. 6398, pp. 848-851, 1992.
56. T. F. Deuel, R. M. Senior, D. Chang, G. L. Griffin, R. L. Heinrikson, and E. T. Kaiser, "Platelet factor 4 is chemotactic for neutrophils and monocytes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 7, pp. 4584-4587, 1981.
57. M. Ghasemzadeh, Z. S. Kaplan, I. Alwis et al., "The CXCR1/2 ligandNAP-2 promotes directed intravascular leukocyte migration through platelet thrombi, " Blood, vol. 121, no. 22, pp. 4555-4566, 2013.
58. G. Nimeri, L. Öhman, H. Elwing, J. Wetterö, and T. Bengtsson, "The influence of plasma proteins and platelets on oxygen radical production and F-actin distribution in neutrophils adhering to polymer surfaces, " Biomaterials, vol. 23, no. 8, pp. 1785-1795, 2002.
59. G. Nimeri, M. Majeed, H. Elwing, L. Öhman, J. Wetterö, and T. Bengtsson, "Oxygen radical production in neutrophils interacting with platelets and surface-immobilized plasma proteins: role of tyrosine phosphorylation, " Journal of Biomedical Materials Research-Part A, vol. 67, no. 2, pp. 439-447, 2003.
60. J. Wetterö, T. Bengtsson, and P. Tengvall, "Complement activation on immunoglobulin G-coated hydrophobic surfaces enhances the release of oxygen radicals from neutrophils through an actin-dependentmechanism, " Journal of Biomedical Materials Research, vol. 51, no. 4, pp. 742-751, 2000.
61. S. C. P. Cachinho and F. Pu, "Free radical production in immune cell systems induced by Ti, Ti6Al4V and SS assessed by chemiluminescence probe pholasin assay, " International Journal of Biomaterials, vol. 2012, Article ID 380845, 7 pages, 2012.
62. A. Itälä, V. V. Välimäki, R. Kiviranta et al., "Molecular biologic comparison of new bone formation and resorption on mizcrorough and smooth bioactive glass microspheres, " Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 65, no. 1, pp. 163-170, 2003.
63. L. Liu, H. Elwing, A. Karlsson, G. Nimeri, and C. Dahlgren, "Surface-related triggering of the neutrophil respiratory burst. Characterization of the response induced by IgG adsorbed to hydrophilic and hydrophobic glass surfaces, " Clinical and Experimental Immunology, vol. 109, no. 1, pp. 204-210, 1997.
64. V. Brinkmann, U. Reichard, C. Goosmann et al., "Neutrophil extracellular traps kill bacteria, " Science, vol. 303, no. 5663, pp. 1532-1535, 2004.
65. E. Kolaczkowska and P. Kubes, "Neutrophil recruitment and function in health and inflammation, " Nature Reviews Immunology, vol. 13, no. 3, pp. 159-175, 2013.
66. C. Trezzini, T. W. Jungi, P. Kuhnert, and E. Peterhans, "Fibrinogen association with human monocytes: evidence for constitutive expression of fibrinogen receptors and for involvement of Mac-1 (CD18, CR3) in the binding, " Biochemical and Biophysical Research Communications, vol. 156, no. 1, pp. 477-484, 1988.
67. D. C. Altieri, P. M. Mannucci, and A. M. Capitanio, "Binding of fibrinogen to human monocytes, " The Journal of Clinical Investigation, vol. 78, no. 4, pp. 968-976, 1986.
68. L. Mesure, G. de Visscher, I. Vranken, A. Lebacq, and W. Flameng, "Gene expression study of monocytes/macrophages during early foreign body reaction and identification of potential precursors of myofibroblasts, " PLoS ONE, vol. 5, no. 9, Article ID e12949, 2010.
69. J. A. Jones, D. T. Chang, H. Meyerson et al., "Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells, " Journal of BiomedicalMaterialsResearchPartA, vol. 83, no. 3, pp. 585-596, 2007.
70. A. D. Lynn, T. R. Kyriakides, and S. J. Bryant, "Characterization of the in vitro macrophage response and in vivo host response to poly(ethylene glycol)-based hydrogels, " Journal of Biomedical Materials Research. Part A, vol. 93, no. 3, pp. 941-953, 2010.
71. Q. Zhao, N. Topham, J. M. Anderson, A. Hiltner, G. Lodoen, and C. R. Payet, "Foreign-body giant cells and polyurethane biostability: in vivo correlation of cell adhesion and surface cracking, " Journal of Biomedical Materials Research, vol. 25, no. 2, pp. 177-183, 1991.
72. D. M. Underhill and H. S. Goodridge, "Information processing during phagocytosis, " Nature Reviews Immunology, vol. 12, no. 7, pp. 492-502, 2012.
73. A. M. Labrousse, E. Meunier, J. Record et al., "Frustrated phagocytosis on micro-patterned immune complexes to characterize lysosome movements in livemacrophages, " Frontiers in Immunology, vol. 2, p. 51, 2011.
74. D. M. Mosser and J. P. Edwards, "Exploring the full spectrum of macrophage activation, " Nature Reviews. Immunology, vol. 8, no. 12, pp. 958-969, 2008.
75. K. Garg, N. A. Pullen, C. A. Oskeritzian, J. J. Ryan, and G. L. Bowlin, "Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds, " Biomaterials, vol. 34, no. 18, pp. 4439-4451, 2013.
76. T. R. Kyriakides, M. J. Foster, G. E. Keeney et al., "The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation, " The American Journal of Pathology, vol. 165, no. 6, pp. 2157-2166, 2004.
77. P. R. Burd, W. C. Thompson, E. E. Max, and F. C. Mills, "Activated mast cells produce interleukin 13, " The Journal of Experimental Medicine, vol. 181, no. 4, pp. 1373-1380, 1995.
78. R. Venkayya, M. Lam, M. Willkom, G. Grünig, D. B. Corry, and D. J. Erle, "The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells, " American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 2, pp. 202-208, 2002.
79. N. Kanbe, M. Kurosawa, T. Yamashita, F. Kurimoto, Y. Yanagihara, and Y. Miyachi, "Cord-blood-derived human cultured mast cells produce interleukin 13 in the presence of stem cell factor, " International Archives of Allergy and Immunology, vol. 119, no. 2, pp. 138-142, 1999.
80. R. Rezzani, L. Rodella, G. M. Tartaglia, C. Paganelli, P. Sapelli, and R. Bianchi, "Mast cells and the inflammatory response to different implanted biomaterials, " Archives of Histology and Cytology, vol. 67, no. 3, pp. 211-217, 2004.
81. L. Tang, T. A. Jennings, and J. W. Eaton, "Mast cells mediate acute inflammatory responses to implanted biomaterials, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 15, pp. 8841-8846, 1998.
82. L. Christenson, L. Wahlberg, and P. Aebischer, "Mast cells and tissue reaction to intraperitoneally implanted polymer capsules, " Journal of Biomedical Materials Research, vol. 25, no. 9, pp. 1119-1131, 1991.
83. N. Kanbe, M. Kurosawa, H. Nagata, H. Saitoh, and Y. Miyachi, "Cord blood-derived human culturedmast cells produce transforming growth factor beta1, " Clinical and Experimental Allergy, vol. 29, no. 1, pp. 105-113, 1999.
84. F. Levi-Schaffer, K. F. Austen, P. M. Gravallese, and R. L. Stevens, "Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 17, pp. 6485-6488, 1986.
85. E. T. Dayton, P. Pharr, M. Ogawa et al., "3T3 fibroblasts induce cloned interleukin 3-dependent mouse mast cells to resemble connective tissue mast cells in granular constituency, " Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 2, pp. 569-572, 1988.
86. T. Nakayama, L. Yao, and G. Tosato, "Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors, "The Journal of Clinical Investigation, vol. 114, no. 9, pp. 1317-1325, 2004.
87. W. R. Roche, "Mast cells and tumour angiogenesis: the tumourmediated release of an endothelial growth factor from mast cells, " International Journal of Cancer, vol. 36, no. 6, pp. 721-728, 1985.
88. D. Ribatti and E. Crivellato, "Mast cells, angiogenesis, and tumour growth, " Biochimica et Biophysica Acta, vol. 1822, no. 1, pp. 2-8, 2012.
89. J. Yang, B. Jao, A. K. Mcnally, and J. M. Anderson, "In vivo quantitative and qualitative assessment of foreign body giant cell formation on biomaterials in mice deficient in natural killer lymphocyte subsets, mast cells, or the interleukin-4 receptorα and in severe combined immunodeficient mice, " Journal of Biomedical Materials Research. Part A, vol. 102, no. 6, pp. 2017-2023, 2014.
90. A. Rodriguez, S. R. MacEwan, H. Meyerson, J. T. Kirk, and J.M. Anderson, "The foreign body reaction in T-cell-deficient mice, " Journal of Biomedical Materials Research-Part A, vol. 90, no. 1, pp. 106-113, 2009.
91. S. Goodman, J.-S. Wang, D. Regula, and P. Aspenberg, "Tlymphocytes are not necessary for particulate polyethyleneinduced macrophage recruitment: histologic studies of the rat tibia, " Acta Orthopaedica, vol. 65, no. 2, pp. 157-160, 1994.
92. M. Yokoyama, T. Nakahashi, T. Nishimura et al., "Adhesion behavior of rat lymphocytes to poly(ether)-poly(amino acid) block and graft copolymers, " Journal of Biomedical Materials Research, vol. 20, no. 7, pp. 867-878, 1986.
93. A. Rodriguez, G. Voskerician, H. Meyerson, S. R. MacEwan, and J. M. Anderson, "T cell subset distributions following primary and secondary implantation at subcutaneous biomaterial implant sites, " Journal of Biomedical Materials Research Part A, vol. 85, no. 2, pp. 556-565, 2008.
94. J. M. Curtsinger, C. S. Schmidt, A. Mondino et al., "Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells, " Journal of Immunology, vol. 162, no. 6, pp. 3256-3262, 1999.
95. A. Rodriguez and J. M. Anderson, "Evaluation of clinical biomaterial surface effects on T lymphocyte activation, " Journal of BiomedicalMaterials Research-Part A, vol. 92, no. 1, pp. 214-220, 2010.
96. J. E. Smith-Garvin, G. A. Koretzky, and M. S. Jordan, "T cell activation, " Annual Review of Immunology, vol. 27, pp. 591-619, 2009.
97. W. G. Brodbeck, M. MacEwan, E. Colton, H. Meyerson, and J. M. Anderson, "Lymphocytes and the foreign body response: lymphocyte enhancement ofmacrophage adhesion and fusion, " Journal of Biomedical Materials Research Part A, vol. 74, no. 2, pp. 222-229, 2005.
98. D. T. Chang, E. Colton, and J. M. Anderson, "Paracrine and juxtacrine lymphocyte enhancement of adherent macrophage and foreign body giant cell activation, " Journal of Biomedical Materials Research Part A, vol. 89, no. 2, pp. 490-498, 2009.
99. D. T. Chang, J. A. Jones, H. Meyerson et al., "Lymphocyte/ macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production, " Journal of Biomedical Materials Research. Part A, vol. 87, no. 3, pp. 676-687, 2008.
100. D.W. Grainger, "All charged up about implanted biomaterials, " Nature Biotechnology, vol. 31, no. 6, pp. 507-509, 2013.
101. E.-C. Shen, T.-C. Chou, C.-H. Gau, H.-P. Tu, Y.-T. Chen, and E. Fu, "Releasing growth factors fromactivated human platelets after chitosan stimulation: a possible bio-material for plateletrich plasma preparation, " Clinical Oral Implants Research, vol. 17, no. 5, pp. 572-578, 2006.
102. R. J. Pitsch, D. J. Minion, M. L. Goman, J. A. van Aalst, P. L. Fox, and L. M. Graham, "Platelet-derived growth factor production by cells from Dacron grafts implanted in a canine model, " Journal of Vascular Surgery, vol. 26, no. 1, pp. 70-78, 1997.
103. S. S. Jensen, N. Broggini, G. Weibrich, E. Hjôrting-Hansen, R. Schenk, and D. Buser, "Bone regeneration in standardized bone defects with autografts or bone substitutes in combination with platelet concentrate: a histologic and histomorphometric study in the mandibles of minipigs, " International Journal of Oral and Maxillofacial Implants, vol. 20, no. 5, pp. 703-712, 2005.
104. S. Chen, J. A. Jones, Y. Xu, H.-Y. Low, J. M. Anderson, and K. W. Leong, "Characterization of topographical effects on macrophage behavior in a foreign body response model, " Biomaterials, vol. 31, no. 13, pp. 3479-3491, 2010.
105. P. Bao, A. Kodra, M. Tomic-Canic, M. S. Golinko, H. P. Ehrlich, and H. Brem, "The role of vascular endothelial growth factor in wound healing, "The Journal of Surgical Research, vol. 153, no. 2, pp. 347-358, 2009.
106. K. Garg, S. A. Sell, P. Madurantakam, and G. L. Bowlin, "Angiogenic potential of human macrophages on electrospun bioresorbable vascular grafts, " Biomedical Materials, vol. 4, no. 3, Article ID 031001, 2009.
107. K. Mustafa, J. Rubinstein, B. S. Lopez, and K. Arvidson, "Production of transforming growth factor β1 and prostaglandin E2 by osteoblast-like cells cultured on titanium surfaces blasted with TiO2 particles, " Clinical Oral Implants Research, vol. 14, no. 1, pp. 50-56, 2003.
108. R. F. Diegelmann and M. C. Evans, "Wound healing: an overview of acute, fibrotic and delayed healing, " Frontiers in Bioscience, vol. 9, pp. 283-289, 2004.
109. P. R. Castro, S. M. Marques, P. P. Campos et al., "Kinetics of implant-induced inflammatory angiogenesis in abdominal muscle wall in mice, " Microvascular Research, vol. 84, no. 1, pp. 9-15, 2012.
110. T. Oviedo-Socarrás, A. C. Vasconcelos, I. X. Barbosa, N. B. Pereira, P. P. Campos, and S. P. Andrade, "Diabetes alters inflammation, angiogenesis, and fibrogenesis in intraperitoneal implants in rats, " Microvascular Research, vol. 93, pp. 23-29, 2014.
111. R. O. Hynes, "The extracellular matrix: not just pretty fibrils, " Science, vol. 326, no. 5957, pp. 1216-1219, 2009.
112. A. R. de Fougerolles and V. E. Koteliansky, "Regulation of monocyte gene expression by the extracellular matrix and its functional implications, " Immunological Reviews, vol. 186, pp. 208-220, 2002.
113. B. D. Ratner and S. J. Bryant, "Biomaterials: where we have been and where we are going, " Annual Review of Biomedical Engineering, vol. 6, pp. 41-75, 2004.
114. B. D. Ratner, "Reducing capsular thickness and enhancing angiogenesis around implant drug release systems, " Journal of Controlled Release, vol. 78, no. 1-3, pp. 211-218, 2002.
115. S. Akira, S. Uematsu, and O. Takeuchi, "Pathogen recognition and innate immunity, " Cell, vol. 124, no. 4, pp. 783-801, 2006.
116. J. J. Oppenheim, P. Tewary, G. De La Rosa, and D. Yang, "Alarmins initiate host defense, " Advances in Experimental Medicine and Biology, vol. 601, pp. 185-194, 2007.
117. D. Yang, F. Wei, P. Tewary, O.M. Z. Howard, and J. J. Oppenheim, "Alarmin-induced cell migration, " European Journal of Immunology, vol. 43, no. 6, pp. 1412-1418, 2013.
118. M. E. Bianchi, "DAMPs, PAMPs and alarmins: all we need to know about danger, " Journal of Leukocyte Biology, vol. 81, no. 1, pp. 1-5, 2007.
119. K. R. Diener, N. Al-Dasooqi, E. L. Lousberg, and J. D. Hayball, "The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer, " Immunology and Cell Biology, vol. 91, no. 7, pp. 443-450, 2013.
120. M. E. Bianchi, M. Beltrame, and G. Paonessa, "Specific recognition of cruciform DNA by nuclear protein HMGl, " Science, vol. 243, no. 4894, pp. 1056-1059, 1989.
121. M. E. Bianchi and M. Beltrame, "Flexing DNA: HMG-box proteins and their partners, " The American Journal of Human Genetics, vol. 63, no. 6, pp. 1573-1577, 1998.
122. H. Wang, O. Bloom, M. Zhang et al., "HMG-1 as a late mediator of endotoxin lethality in mice, " Science, vol. 285, no. 5425, pp. 248-251, 1999.
123. L.-C. Li, J. Gao, and J. Li, "Emerging role ofHMGB1 in fibrotic diseases, " Journal of Cellular andMolecularMedicine, vol. 18, no. 12, pp. 2331-2339, 2014.
124. P. Scaffidi, T. Misteli, and M. E. Bianchi, "Release of chromatin protein HMGB1 by necrotic cells triggers inflammation, " Nature, vol. 418, no. 6894, pp. 191-195, 2002.
125. I. E. Dumitriu, P. Baruah, B. Valentinis et al., "Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products, " Journal of Immunology, vol. 174, no. 12, pp. 7506-7515, 2005.
126. S.-A. Lee, M. S. Kwak, S. Kim, and J.-S. Shin, "The role of high mobility group box 1 in innate immunity, " Yonsei Medical Journal, vol. 55, no. 5, pp. 1165-1176, 2014.
127. L. Campana, L. Bosurgi, M. E. Bianchi, A. A. Manfredi, and P. Rovere-Querini, "Requirement of HMGB1 for stromal cellderived factor-1/CXCL12-dependent migration of macrophages and dendritic cells, " Journal of Leukocyte Biology, vol. 86, no. 3, pp. 609-615, 2009.
128. A. Rouhiainen, J. Kuja-Panula, E. Wilkman et al., "Regulation of monocyte migration by amphoterin (HMGB1), " Blood, vol. 104, no. 4, pp. 1174-1182, 2004.
129. N. Maugeri, P. Rovere-Querini, M. Baldini et al., "Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a Candidate for microvessel injury in sytemic sclerosis, " Antioxidants&Redox Signaling, vol. 20, no. 7, pp. 1060-1074, 2014.
130. L. M. Ayer, J.-L. Senecal, L. Martin, G. H. Dixon, and M. J. Fritzler, "Antibodies to highmobility group proteins in systemic sclerosis, " Journal of Rheumatology, vol. 21, no. 11, pp. 2071-2075, 1994.
131. S. M. Rowe, P. L. Jackson, G. Liu et al., "Potential role of highmobility group box 1 in cystic fibrosis airway disease, " American Journal of Respiratory and Critical CareMedicine, vol. 178, no. 8, pp. 822-831, 2008.
132. M. Entezari, D. J. Weiss, R. Sitapara et al., "Inhibition of highmobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis, " Molecular Medicine, vol. 18, no. 1, pp. 477-485, 2012.
133. W.-S. Ge, J.-X. Wu, J.-G. Fan, Y.-J. Wang, and Y.-W. Chen, "Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells, " World Journal of Gastroenterology, vol. 17, no. 36, pp. 4090-4098, 2011.
134. M. Ebina, H. Taniguchi, T. Miyasho et al., "Gradual increase of high mobility group protein B1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis, " PulmonaryMedicine, vol. 2011, Article ID 916486, 9 pages, 2011.
135. N. Hamada, T. Maeyama, T. Kawaguchi et al., "The role of high mobility group box1 in pulmonary fibrosis, "American Journal of Respiratory Cell and Molecular Biology, vol. 39, no. 4, pp. 440-447, 2008.
136. A. Chitanuwat, N. Laosrisin, and N. Dhanesuan, "Role of HMGB1 in proliferation and migration of human gingival and periodontal ligament fibroblasts, " Journal of Oral Science, vol. 55, no. 1, pp. 45-50, 2013.
137. Q. Zhang, S. O'Hearn, S. L. Kavalukas, and A. Barbul, "Role of high mobility group box 1 (HMGB1) in wound healing, " The Journal of Surgical Research, vol. 176, no. 1, pp. 343-347, 2012.
138. C. Hou, J. Kong, Y. Liang et al., "HMGB1 contributes to allergeninduced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts, " Cellular & Molecular Immunology, 2014.
139. E. Ranzato, M. Patrone, M. Pedrazzi, and B. Burlando, "Hmgb1 promotes wound healing of 3T3 mouse fibroblasts via RAGEdependent ERK1/2 activation, " Cell Biochemistry and Biophysics, vol. 57, no. 1, pp. 9-17, 2010.
140. H.Wähämaa, H. Schierbeck, H. S. Hreggvidsdottir et al., "High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts, " Arthritis Research & Therapy, vol. 13, no. 4, article R136, 2011.
141. A. Abe, T. Kuwata, C. Yamauchi, Y. Higuchi, and A. Ochiai, "High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts, " Pathology International, vol. 64, no. 6, pp. 267-275, 2014.
142. J. E. Babensee, "Interaction of dendritic cells with biomaterials, " Seminars in Immunology, vol. 20, no. 2, pp. 101-108, 2008.
143. A. L. Rankin, J. B. Mumm, E. Murphy et al., "IL-33 induces IL- 13-dependent cutaneous fibrosis, " Journal of Immunology, vol. 184, no. 3, pp. 1526-1535, 2010.
144. L. R. Lopetuso, F. Scaldaferri, and T. T. Pizarro, "Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis, " Fibrogenesis & Tissue Repair, vol. 5, no. 1, article 18, 2012.
145. Q. Gao, Y. Li, and M. Li, "The potential role of IL-33/ST2 signaling in fibrotic diseases, " Journal of Leukocyte Biology, 2015.
146. P. Marvie, M. Lisbonne, A. L'Helgoualc'h et al., "Interleukin- 33 overexpression is associated with liver fibrosis in mice and humans, " Journal of Cellular andMolecularMedicine, vol. 14, no. 6, pp. 1726-1739, 2010.
147. I. G. Luzina, P. Kopach, V. Lockatell et al., "Interleukin-33 potentiates bleomycin-induced lung injury, " American Journal of Respiratory Cell andMolecular Biology, vol. 49, no. 6, pp. 999-1008, 2013.
148. T. McHedlidze, M. Waldner, S. Zopf et al., "Interleukin-33- dependent innate lymphoid cells mediate hepatic fibrosis, " Immunity, vol. 39, no. 2, pp. 357-371, 2013.
149. E. Lefrançais and C. Cayrol, "Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members, " European Cytokine Network, vol. 23, no. 4, pp. 120-127, 2012.
150. E. Lefrancais, S. Roga, V. Gautier et al., "IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 5, pp. 1673-1678, 2012.
151. M. Komai-Koma, D. Xu, Y. Li, A. N. J. McKenzie, I. B. McInnes, and F. Y. Liew, "IL-33 is a chemoattractant for human Th2 cells, " European Journal of Immunology, vol. 37, no. 10, pp. 2779-2786, 2007.
152. M. D. Smithgall, M. R. Comeau, B.-R. Park Yoon, D. Kaufman, R. Armitage, and D. E. Smith, "IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells, " International Immunology, vol. 20, no. 8, pp. 1019-1030, 2008.
153. J. Schmitz, A. Owyang, E. Oldhamet al., "IL-33, an interleukin- 1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, " Immunity, vol. 23, no. 5, pp. 479-490, 2005.
154. D. Li, R. Guabiraba, A.-G. Besnard et al., "IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice, " The Journal of Allergy and Clinical Immunology, vol. 134, no. 6, pp. 1422-1432, 2014.
155. R. O. Hynes, "Integrins: versatility, modulation, and signaling in cell adhesion, " Cell, vol. 69, no. 1, pp. 11-25, 1992.
156. C. C. Kumar, "Signaling by integrin receptors, " Oncogene, vol. 17, no. 11, pp. 1365-1373, 1998.
157. A. K. Behera, E. Hildebrand, S. Uematsu, S. Akira, J. Coburn, and L. T. Hu, "Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin α3β1, "The Journal of Immunology, vol. 177, no. 1, pp. 657-664, 2006.
158. S. Al-Okla, C. Chatenay-Rivauday, J.-P. Klein, and D. Wachsmann, "Involvement of α5β1 integrins in interleukin 8 production induced by oral viridans streptococcal protein I/IIf in cultured endothelial cells, " Cellular Microbiology, vol. 1, no. 2, pp. 157-168, 1999.
159. T. E. Secott, T. L. Lin, and C. C. Wu, "Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein facilitates M-cell targeting and invasion through a fibronectin bridge with host integrins, " Infection and Immunity, vol. 72, no. 7, pp. 3724-3732, 2004.
160. T. Vorup-Jensen, C. V. Carman, M. Shimaoka, P. Schuck, J. Svitel, and T. A. Springer, "Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin αXβ2, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 5, pp. 1614-1619, 2005.
161. K. Suehiro, J. Mizuguchi, K. Nishiyama, S. Iwanaga, D. H. Farrell, and S. Ohtaki, "Fibrinogen binds to integrin α5β1 via the carboxyl-terminal RGD site of the Aα-chain, " Journal of Biochemistry, vol. 128, no. 4, pp. 705-710, 2000.
162. B. B. Gowen, T. K. Borg, A. Ghaffar, and E. P. Mayer, "Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors, " Matrix Biology, vol. 19, no. 1, pp. 61-71, 2000.
163. T. Guo, W. Kang, D. Xiao, R. Duan, W. Zhi, and J. Weng, "Molecular docking characterization of a four-domain segment of human fibronectin encompassing theRGDloopwith hydroxyapatite, " Molecules, vol. 19, no. 1, pp. 149-158, 2013.
164. A. Zanetti, G. Conforti, S. Hess et al., "Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membrane, " Blood, vol. 84, no. 4, pp. 1116-1123, 1994.
165. C. A. Hoesli, A. Garnier, P.-M. Juneau, P. Chevallier, C. Duchesne, and G. Laroche, "A fluorophore-tagged RGD peptide to control endothelial cell adhesion to micropatterned surfaces, " Biomaterials, vol. 35, no. 3, pp. 879-890, 2014.
166. L. Tang, "Mechanisms of fibrinogen domains: biomaterial interactions, " Journal of Biomaterials Science, Polymer Edition, vol. 9, no. 12, pp. 1257-1266, 1998.
167. M. Yaseen, X. Zhao, A. Freund, A. M. Seifalian, and J. R. Lu, "Surface structural conformations of fibrinogen polypeptides for improved biocompatibility, " Biomaterials, vol. 31, no. 14, pp. 3781-3792, 2010.
168. F. Barbé, T. Douglas, and M. Saleh, "Advances in Nod-like receptors (NLR) biology, " Cytokine & Growth Factor Reviews, vol. 25, no. 6, pp. 681-697, 2014.
169. S. Akira, "Mammalian Toll-like receptors, " Current Opinion in Immunology, vol. 15, no. 1, pp. 5-11, 2003.
170. M. Oosting, S.-C. Cheng, J. M. Bolscher et al., "Human TLR10 is an anti-inflammatory pattern-recognition receptor, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 42, pp. E4478-E4484, 2014.
171. M. Oldenburg, A. Krüger, R. Ferstl et al., "TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance- forming modification, " Science, vol. 337, no. 6098, pp. 1111-1115, 2012.
172. R. Medzhitov, "Toll-like receptors and innate immunity, " Nature Reviews Immunology, vol. 1, no. 2, pp. 135-145, 2001.
173. K. Takeda, T. Kaisho, and S. Akira, "Toll-like receptors, " Annual Review of Immunology, vol. 21, pp. 335-376, 2003.
174. T. Kawai and S. Akira, "The role of pattern-recognition receptors in innate immunity: update on toll-like receptors, " Nature Immunology, vol. 11, no. 5, pp. 373-384, 2010.
175. R. Maitra, C. C. Clement, B. Scharf et al., "Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysis, " Molecular Immunology, vol. 47, no. 2-3, pp. 175-184, 2009.
176. T. Lähdeoja, J. Pajarinen, V.-P. Kouri, T. Sillat, J. Salo, and Y. T. Konttinen, "Toll-like receptors and aseptic loosening of hip endoprosthesis-a potential to respond against danger signals?" Journal of OrthopaedicResearch, vol. 28, no. 2, pp. 184-190, 2010.
177. Y. Tamaki, Y. Takakubo, K. Goto et al., "Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants, " Journal of Rheumatology, vol. 36, no. 3, pp. 598-608, 2009.
178. R. D. Valladares, C. Nich, S. Zwingenberger et al., "Toll-like receptors-2 and 4 are overexpressed in an experimental model of particle-induced osteolysis, " Journal of Biomedical Materials Research, Part A, vol. 102, no. 9, pp. 3004-3011, 2014.
179. R. Maitra, C. C. Clement, G. M. Crisi, N. Cobelli, and L. Santambrogio, "Immunogenecity of modified alkane polymers is mediated through TLR1/2 activation, " PLoS ONE, vol. 3, no. 6, Article ID e2438, 2008.
180. B. Shokouhi, C. Coban, V. Hasirci et al., "The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells, " Biomaterials, vol. 31, no. 22, pp. 5759-5771, 2010.
181. T. H. Rogers and J. E. Babensee, "Altered adherent leukocyte profile on biomaterials in Toll-like receptor 4 deficient mice, " Biomaterials, vol. 31, no. 4, pp. 594-601, 2010.
182. S.-Y. Seong and P. Matzinger, "Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses, " Nature Reviews Immunology, vol. 4, no. 6, pp. 469-478, 2004.
183. A. S. Hoffman, "Principles governing biomolecule interactions at foreign interfaces, " Journal of Biomedical Materials Research, vol. 8, no. 3, pp. 77-83, 1974.
184. A.M. Piccinini and K. S. Midwood, "DAMPening inflammation by modulating TLR signalling, " Mediators of Inflammation, vol. 2010, Article ID672395, 21 pages, 2010.
185. S. T. Smiley, J. A. King, and W. W. Hancock, "Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4, " Journal of Immunology, vol. 167, no. 5, pp. 2887-2894, 2001.
186. C. P. Hodgkinson, K. Patel, and S. Ye, "Functional Toll-like receptor 4 mutations modulate the response to fibrinogen, " Thrombosis and Haemostasis, vol. 100, no. 2, pp. 301-307, 2008.
187. Y. Okamura, M. Watari, E. S. Jerud et al., "The extra domain A of fibronectin activates Toll-like receptor 4, " The Journal of Biological Chemistry, vol. 276, no. 13, pp. 10229-10233, 2001.
188. V. O. Millien, W. Lu, J. Shaw et al., "Cleavage of fibrinogen by proteinases elicits allergic responses through toll-like receptor 4, " Science, vol. 341, no. 6147, pp. 792-796, 2013.
189. R. M. Kelsh and P. J. McKeown-Longo, "Topographical changes in extracellular matrix: activation of TLR4 signaling and solid tumor progression, " Trends in Cancer Research, vol. 9, pp. 1-13, 2013.
190. M. M. Khan, C. Gandhi, N. Chauhan et al., "Alternativelyspliced extra domain a of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice, " Stroke, vol. 43, no. 5, pp. 1376-1382, 2012.
191. J. S. Park, D. Svetkauskaite, Q. He et al., "Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein, " The Journal of Biological Chemistry, vol. 279, no. 9, pp. 7370-7377, 2004.
192. J. S. Park, F. Gamboni-Robertson, Q. He et al., "High mobility group box 1 protein interacts with multiple Toll-like receptors, " The American Journal of Physiology-Cell Physiology, vol. 290, no. 3, pp. C917-C924, 2006.
193. M. W. Laschke, V. Augustin, S. Kleer, T. Tschernig, and M. D. Menger, "Locally applied macrophage-activating lipopeptide-2 (MALP-2) promotes early vascularization of implanted porous polyethylene (Medpor), " Acta Biomaterialia, vol. 10, no. 11, pp. 4661-4669, 2014.
194. M. Kulka and D. D. Metcalfe, "TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin, " Molecular Immunology, vol. 43, no. 10, pp. 1579-1586, 2006.
195. S. R. Jacobs and B. Damania, "NLRs, inflammasomes, and viral infection, " Journal of Leukocyte Biology, vol. 92, no. 3, pp. 469-477, 2012.
196. F. Martinon, A. Mayor, and J. Tschopp, "The inflammasomes: guardians of the body, " Annual Review of Immunology, vol. 27, pp. 229-265, 2009.
197. M. R. de Zoete, N.W. Palm, S. Zhu, and R. A. Flave, "Inflammasomes, " Cold Spring Harbor Perspectives in Biology, vol. 6, no. 12, Article ID a016287, 2014.
198. F. Martinon, K. Burns, and J. Tschopp, "The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β, " Molecular Cell, vol. 10, no. 2, pp. 417-426, 2002.
199. R. L. Brunette, J. M. Young, D. G. Whitley, I. E. Brodsky, H. S. Malik, and D. B. Stetson, "Extensive evolutionary and functional diversity among mammalian AIM2-like receptors, " The Journal of ExperimentalMedicine, vol. 209, no. 11, pp. 1969-1983, 2012.
200. V. Hornung, A. Ablasser, M. Charrel-Dennis et al., "AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC, " Nature, vol. 458, no. 7237, pp. 514-518, 2009.
201. T. Jin, A. Perry, P. Smith, J. Jiang, and T. S. Xiao, "Structure of the absent in melanoma 2 (AIM2) pyrin domain provides insights into the mechanisms of AIM2 autoinhibition and inflammasome assembly, " The Journal of Biological Chemistry, vol. 288, no. 19, pp. 13225-13235, 2013.
202. T. Fernandes-Alnemri, J.-W. Yu, P. Datta, J. Wu, and E. S. Alnemri, "AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA, " Nature, vol. 458, no. 7237, pp. 509-513, 2009.
203. L. Franchi, T. Eigenbrod, R. Muñoz-Planillo, and G. Nuñez, "The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis, " Nature Immunology, vol. 10, no. 3, pp. 241-247, 2009.
204. M. Lamkanfi and V. M. Dixit, "Mechanisms and functions of inflammasomes, " Cell, vol. 157, no. 5, pp. 1013-1022, 2014.
205. S. J. Riedl and G. S. Salvesen, "The apoptosome: signalling platform of cell death, " Nature Reviews Molecular Cell Biology, vol. 8, no. 5, pp. 405-413, 2007.
206. A. Lu and H. Wu, "Structural mechanisms of inflammasome assembly, " FEBS Journal, vol. 282, no. 3, pp. 435-444, 2015.
207. N. Kayagaki, S. Warming, M. Lamkanfi et al., "Non-canonical inflammasome activation targets caspase-11, " Nature, vol. 479, no. 7371, pp. 117-121, 2011.
208. M. Lamkanfi, A. Sarkar, L. VandeWalle et al., "Inflammasomedependent release of the alarmin HMGB1 in endotoxemia, " Journal of Immunology, vol. 185, no. 7, pp. 4385-4392, 2010.
209. E. A. Miao, J. V. Rajan, and A. Aderem, "Caspase-1-induced pyroptotic cell death, " Immunological Reviews, vol. 243, no. 1, pp. 206-214, 2011.
210. M. Kovarova, P. R. Hesker, L. Jania et al., "NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice, " The Journal of Immunology, vol. 189, no. 4, pp. 2006-2016, 2012.
211. B. F. Py, M. Jin, B. N. Desai et al., "Caspase-11 controls interleukin-1β release through degradation of TRPC1, " Cell Reports, vol. 6, no. 6, pp. 1122-1128, 2014.
212. C. Stehlik and A. Dorfleutner, "COPs and POPs: modulators of inflammasome activity, " Journal of Immunology, vol. 179, no. 12, pp. 7993-7998, 2007.
213. F. Bedoya, L. L. Sandler, and J. A. Harton, "Pyrin-only protein 2 modulates NF-κB and Disrupts ASC:CLR interactions, " Journal of Immunology, vol. 178, no. 6, pp. 3837-3845, 2007.
214. B. Wegiel, R. Larsen, D. Gallo et al., "Macrophages sense and kill bacteria through carbon monoxide-dependent inflammasome activation, "The Journal of Clinical Investigation, vol. 124, no. 11, pp. 4926-4940, 2014.
215. K. Tsuchiya, H. Hara, R. Fang et al., "The adaptor ASC exacerbates lethal Listeria monocytogenes infection by mediating IL-18 production in an inflammasome-dependent and -independent manner, " European Journal of Immunology, vol. 44, no. 12, pp. 3696-3707, 2014.
216. V. A. K. Rathinam, Z. Jiang, S. N. Waggoner et al., "The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses, " Nature Immunology, vol. 11, no. 5, pp. 395-402, 2010.
217. T. Ichinohe, T. Yamazaki, T. Koshiba, and Y. Yanagi, "Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation afterRNAvirus infection, " Proceedings of theNational Academy of Sciences of the United States of America, vol. 110, no. 44, pp. 17963-17968, 2013.
218. D. Pietrella, N. Pandey, E. Gabrielli et al., "Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome, " European Journal of Immunology, vol. 43, no. 3, pp. 679-692, 2013.
219. O. Gross, H. Poeck, M. Bscheider et al., "Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence, " Nature, vol. 459, no. 7245, pp. 433-436, 2009.
220. T. Ichinohe, I. K. Pang, and A. Iwasaki, "Influenza virus activates inflammasomes via its intracellular M2 ion channel, " Nature Immunology, vol. 11, no. 5, pp. 404-410, 2010.
221. Y. Qiao, P. Wang, J. Qi, L. Zhang, and C. Gao, "TLR-induced NF-κB activation regulates NLRP3 expression in murine macrophages, " FEBS Letters, vol. 586, no. 7, pp. 1022-1026, 2012.
222. F. G. Bauernfeind, G. Horvath, A. Stutz et al., "Cutting edge: NFkappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression, " Journal of Immunology, vol. 183, no. 2, pp. 787-791, 2009.
223. J.A. Gracie, S. E. Robertson, and I. B. McInnes, "Interleukin-18, " Journal of Leukocyte Biology, vol. 73, no. 2, pp. 213-224, 2003.
224. K. Akita, T. Ohtsuki, Y. Nukada et al., "Involvement of caspase- 1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells, " The Journal of Biological Chemistry, vol. 272, no. 42, pp. 26595-26603, 1997.
225. V. Pétrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp, "Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration, " Cell Death and Differentiation, vol. 14, no. 9, pp. 1583-1589, 2007.
226. S. Mariathasan, D. S. Weiss, K. Newton et al., "Cryopyrin activates the inflammasome in response to toxins and ATP, " Nature, vol. 440, no. 7081, pp. 228-232, 2006.
227. L. Franchi, T.-D. Kanneganti, G. R. Dubyak, and G. Núñez, "Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria, " The Journal of Biological Chemistry, vol. 282, no. 26, pp. 18810-18818, 2007.
228. J. P. Grierson and J. Meldolesi, "Shear stress-induced [Ca2+]i transients and oscillations in mouse fibroblasts are mediated by endogenously released ATP, " The Journal of Biological Chemistry, vol. 270, no. 9, pp. 4451-4456, 1995.
229. D. Communi, R. Janssens, N. Suarez-Huerta, B. Robaye, and J.-M. Boeynaems, "Advances in signalling by extracellular nucleotides: the role and transduction mechanisms of P2Y receptors, " Cellular Signalling, vol. 12, no. 6, pp. 351-360, 2000.
230. P. Milner, P. Bodin, A. Loesch, and G. Burnstock, "Increased shear stress leads to differential release of endothelin and ATP from isolated endothelial cells from 4- and 12-month-old male rabbit aorta, " Journal of Vascular Research, vol. 29, no. 6, pp. 420-425, 1992.
231. G.-S. Lee, N. Subramanian, A. I. Kim et al., "The calciumsensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP, " Nature, vol. 492, no. 7427, pp. 123-127, 2012.
232. T. Murakami, J. Ockinger, J. Yu et al., "Critical role for calcium mobilization in activation of the NLRP3 inflammasome, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 28, pp. 11282-11287, 2012.
233. V. Hornung, F. Bauernfeind, A. Halle et al., "Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization, " Nature Immunology, vol. 9, no. 8, pp. 847-856, 2008.
234. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp, "Gout-associated uric acid crystals activate the NALP3 inflammasome, " Nature, vol. 440, no. 7081, pp. 237-241, 2006.
235. F. Bauernfeind, E. Bartok, A. Rieger, L. Franchi, G. Núñez, and V. Hornung, "Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome, " Journal of Immunology, vol. 187, no. 2, pp. 613-617, 2011.
236. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp, "Thioredoxin-interacting protein links oxidative stress to inflammasome activation, " Nature Immunology, vol. 11, no. 2, pp. 136-140, 2010.
237. K. Shimada, T. R. Crother, J. Karlin et al., "Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis, " Immunity, vol. 36, no. 3, pp. 401-414, 2012.
238. C. Dostert, V. Pétrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp, "Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica, " Science, vol. 320, no. 5876, pp. 674-677, 2008.
239. W. Zhang, Y. Cai, W. Xu, Z. Yin, X. Gao, and S. Xiong, "AIM2 facilitates the apoptotic DNA-induced systemic lupus erythematosus via arbitrating macrophage functional maturation, " Journal of Clinical Immunology, vol. 33, no. 5, pp. 925-937, 2013.
240. T. Jin, A. Perry, J. Jiang et al., "Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor, " Immunity, vol. 36, no. 4, pp. 561-571, 2012.
241. V. Sagulenko, S. J. Thygesen, D. P. Sester et al., "AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC, " Cell Death and Differentiation, vol. 20, no. 9, pp. 1149-1160, 2013.
242. J.-D. Sauer, C. E. Witte, J. Zemansky, B. Hanson, P. Lauer, and D. A. Portnoy, "Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol, " Cell Host & Microbe, vol. 7, no. 5, pp. 412-419, 2010.
243. D. D. Crane, T. J. Bauler, T. D. Wehrly, and C. M. Bosio, "MitochondrialROS potentiates indirect activation of the AIM2 inflammasome, " Frontiers in Microbiology, vol. 5, article 438, 2014.
244. L. Liu, M. Yang, R. Kang et al., "HMGB1-DNAcomplex-induced autophagy limits AIM2 inflammasome activation through RAGE, " Biochemical and Biophysical Research Communications, vol. 450, no. 1, pp. 851-856, 2014.
245. M. K. Kukkonen, T. Vehmas, P. Piirilä, and A. Hirvonen, "Genes involved in innate immunity associated with asbestos-related fibrotic changes, " Occupational & Environmental Medicine, vol. 71, no. 1, pp. 48-54, 2014.
246. C. C. Leung, I. T. S. Yu, and W. Chen, "Silicosis, " The Lancet, vol. 379, no. 9830, pp. 2008-2018, 2012.
247. S. L. Cassel, S. C. Eisenbarth, S. S. Iyer et al., "The Nalp3 inflammasome is essential for the development of silicosis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 26, pp. 9035-9040, 2008.
248. R. F. Hamilton Jr., S. A. Thakur, and A. Holian, "Silica binding and toxicity in alveolar macrophages, " Free Radical Biology & Medicine, vol. 44, no. 7, pp. 1246-1258, 2008.
249. P. B. Kopnin, I.V. Kravchenko, V.A. Furalyov, L.N. Pylev, and B. P. Kopnin, "Cell type-specific effects of asbestos on intracellular ROS levels, DNA oxidation and G1 cell cycle checkpoint, " Oncogene, vol. 23, no. 54, pp. 8834-8840, 2004.
250. J. K. Thompson, C. M. Westbom, M. B. MacPherson et al., "Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation, " Particle and Fibre Toxicology, vol. 11, no. 1, article 24, 2014.
251. A. C. Reisetter, L. V. Stebounova, J. Baltrusaitis et al., "Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles, "The Journal of Biological Chemistry, vol. 286, no. 24, pp. 21844-21852, 2011.
252. O. Lunov, T. Syrovets, C. Loos et al., "Amino-functionalized polystyrene nanoparticles activate theNLRP3 inflammasome in human macrophages, " ACS Nano, vol. 5, no. 12, pp. 9648-9657, 2011.
253. L. Burton, D. Paget, N. B. Binder et al., "Orthopedic wear debris mediated inflammatory osteolysis ismediated in part byNALP3 inflammasome activation, " Journal of OrthopaedicResearch, vol. 31, no. 1, pp. 73-80, 2013.
254. M. Winter, H.-D. Beer, V. Hornung, U. Kärmer, R. P. F. Schins, and I. Förster, "Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells, " Nanotoxicology, vol. 5, no. 3, pp. 326-340, 2011.
255. M. S. Caicedo, L. Samelko, K. McAllister, J. J. Jacobs, and N. J. Hallab, "Increasing both CoCrMo-alloy particle size and surface irregularity induces increased macrophage inflammasome activation in vitro potentially through lysosomal destabilization mechanisms, " Journal ofOrthopaedic Research, vol. 31, no. 10, pp. 1633-1642, 2013.
256. E.-J. Yang, S. Kim, J. S. Kim, and I.-H. Choi, "Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles, " Biomaterials, vol. 33, no. 28, pp. 6858-6867, 2012.
257. N. Cobelli, B. Scharf, G. M. Crisi, J. Hardin, and L. Santambrogio, "Mediators of the inflammatory response to joint replacement devices, " Nature Reviews Rheumatology, vol. 7, no. 10, pp. 600-608, 2011.
258. A. Rodriguez, H. Meyerson, and J. M. Anderson, "Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites, " Journal of Biomedical Materials Research. Part A, vol. 89, no. 1, pp. 152-159, 2009.
259. A. D. Lynn and S. J. Bryant, "Phenotypic changes in bone marrow-derived murine macrophages cultured on PEG-based hydrogels activated or not by lipopolysaccharide, " Acta Biomaterialia, vol. 7, no. 1, pp. 123-132, 2011.
260. A. K. Blakney, M. D. Swartzlander, and S. J. Bryant, "The effects of substrate stiffness on the in vitro activation of macrophages and in vivo host response to poly(ethylene glycol)-based hydrogels, " Journal of BiomedicalMaterials Research Part, vol. 100, no. 6, pp. 1375-1386, 2012.
261. J. R. Lukens, J. M. Gross, C. Calabrese et al., "Critical role for inflammasome-independent IL-1beta production in osteomyelitis, " Proceedings of the National Academy of Sciences of theUnited States ofAmerica, vol. 111, no. 3, pp. 1066-1071, 2014.
262. M. G. Netea, A. Simon, F. Van De Veerdonk, B.-J. Kullberg, J. W. M. Van Der Meer, and L. A. B. Joosten, "IL-1β processing in host defense: beyond the inflammasomes, " PLoS Pathogens, vol. 6, no. 2, Article ID e1000661, 2010.
263. S. Provoost, T. Maes, N. S. Pauwels et al., "NLRP3/caspase-1- independent IL-1β production mediates diesel exhaust particleinduced pulmonary inflammation, " Journal of Immunology, vol. 187, no. 6, pp. 3331-3337, 2011.
264. A. F. Malik, R. Hoque, X. Ouyang et al., "Inflammasome components Asc and caspase-1 mediate biomaterial-induced inflammation and foreign body response, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 50, pp. 20095-20100, 2011.
265. S. K. Ippagunta, R. K. S. Malireddi, P. J. Shaw et al., "The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization, " Nature Immunology, vol. 12, no. 10, pp. 1010-1016, 2011.
266. H. Hassan and A. O. Amer, "Cell intrinsic roles of apoptosisassociated speck-like protein in regulating innate and adaptive immune responses, " TheScientificWorldJOURNAL, vol. 11, 6 pages, 2011.
267. G. Ng, K. Sharma, S. M. Ward et al., "Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells, " Immunity, vol. 29, no. 5, pp. 807-818, 2008.
268. S. S. Bhagwat, "Kinase inhibitors for the treatment of inflammatory and autoimmune disorders, " Purinergic Signalling, vol. 5, no. 1, pp. 107-115, 2009.
269. N. Pazyar, A. Feily, and R. Yaghoobi, "An overview of interleukin-1 receptorAntagonist, Anakinra, in the treatment of cutaneous diseases, " Current Clinical Pharmacology, vol. 7, no. 4, pp. 271-275, 2012.
270. B. D. Ratner, "The biocompatibilitymanifesto: biocompatibility for the twenty-first century, " Journal of Cardiovascular Translational Research, vol. 4, no. 5, pp. 523-527, 2011.
271. J. M. Morais, F. Papadimitrakopoulos, and D. J. Burgess, "Biomaterials/ tissue interactions: possible solutions to overcome foreign body response, " AAPS Journal, vol. 12, no. 2, pp. 188-196, 2010.
272. M. B. Rahmany and M. Van Dyke, "Biomimetic approaches to modulate cellular adhesion in biomaterials: a review, " Acta Biomaterialia, vol. 9, no. 3, pp. 5431-5437, 2013.
273. P. Thevenot, W. Hu, and L. Tang, "Surface chemistry influences implant biocompatibility, " Current Topics in Medicinal Chemistry, vol. 8, no. 4, pp. 270-280, 2008.
274. J. N. Barbosa, M. Á. A. Barbosa, and A. P. Águas, "Inflammatory responses and cell adhesion to self-assembled monolayers of alkanethiolates on gold, " Biomaterials, vol. 25, no. 13, pp. 2557-2563, 2004.
275. C. Sperling, R. B. Schweiss, U. Streller, and C. Werner, "In vitro hemocompatibility of self-assembled monolayers displaying various functional groups, " Biomaterials, vol. 26, no. 33, pp. 6547-6557, 2005.
276. S. Kamath, D. Bhattacharyya, C. Padukudru, R. B. Timmons, and L. Tang, "Surface chemistry influences implant-mediated host tissue responses, " Journal of BiomedicalMaterials Research, Part A, vol. 86, no. 3, pp. 617-626, 2008.
277. L. Tang, Y. Wu, and R. B. Timmons, "Fibrinogen adsorption and host tissue responses to plasma functionalized surfaces, " Journal of BiomedicalMaterials Research, vol. 42, no. 1, pp. 156-163, 1998.
278. J. N. Barbosa, P. Madureira, M. A. Barbosa, and A. P. Águas, "The influence of functional groups of self-assembledmonolayers on fibrous capsule formation and cell recruitment, " Journal of BiomedicalMaterials Research. Part A, vol. 76, no. 4, pp. 737-743, 2006.
279. J. N. Barbosa, M. A. Barbosa, and A. P. Água, "Adhesion of human leukocytes to biomaterials: an in vitro study using alkanethiolate monolayers with different chemically functionalized surfaces, " Journal of Biomedical Materials Research Part A, vol. 65, no. 4, pp. 429-434, 2003.
280. M. Källtorp, S. Oblogina, S. Jacobsson, A. Karlsson, P. Tengvall, and P. Thomsen, "In vivo cell recruitment, cytokine release and chemiluminescence response at gold, and thiol functionalized surfaces, " Biomaterials, vol. 20, no. 22, pp. 2123-2137, 1999.
281. M. A. Lan, C. A. Gersbach, K. E. Michael, B. G. Keselowsky, and A. J. García, "Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries, " Biomaterials, vol. 26, no. 22, pp. 4523-4531, 2005.
282. B. G. Keselowsky, D. M. Collard, and A. J. García, "Surface chemistrymodulates focal adhesion composition and signaling through changes in integrin binding, " Biomaterials, vol. 25, no. 28, pp. 5947-5954, 2004.
283. B. G. Keselowsky, D. M. Collard, and A. J. García, "Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 17, pp. 5953-5957, 2005.
284. S. K. Sastry and K. Burridge, "Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics, " Experimental Cell Research, vol. 261, no. 1, pp. 25-36, 2000.
285. B. Bai, J. He, Y.-S. Li, X.-M. Wang, H.-J. Ai, and F.-Z. Cui, "Activation of the ERK1/2 signaling pathway during the osteogenic differentiation of mesenchymal stem cells cultured on substrates modified with various chemical groups, " BioMed Research International, vol. 2013, Article ID 361906, 15 pages, 2013.
286. M. H. Lee, P. Ducheyne, L. Lynch, D. Boettiger, and R. J. Composto, "Effect of biomaterial surface properties on fibronectin-α5β1 integrin interaction and cellular attachment, " Biomaterials, vol. 27, no. 9, pp. 1907-1916, 2006.
287. B. G. Keselowsky, D. M. Collard, and A. J. García, "Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion, " Journal of Biomedical Materials Research Part A, vol. 66, no. 2, pp. 247-259, 2003.
288. I. Hirata, Y. Hioki, M. Toda et al., "Deposition of complement protein C3b on mixed self-assembled monolayers carrying surface hydroxyl andmethyl groups studied by surface plasmon resonance, " Journal of Biomedical Materials Research, Part A, vol. 66, no. 3, pp. 669-676, 2003.
289. J. Benesch, S. Svedhem, S. C. T. Svensson, R. Valiokas, B. Liedberg, and P. Tengvall, "Protein adsorption to oligo(ethylene glycol) self-assembled monolayers: experiments with fibrinogen, heparinized plasma, and serum, " Journal of Biomaterials Science, Polymer Edition, vol. 12, no. 6, pp. 581-597, 2001.
290. A. K. Mcnally and J.M. Anderson, "Complement C3 participation in monocyte adhesion to different surfaces, " Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 21, pp. 10119-10123, 1994.
291. A. Nair, L. Zou, D. Bhattacharyya, R. B. Timmons, and L. Tang, "Species and density of implant surface chemistry affect the extent of foreign body reactions, " Langmuir, vol. 24, no. 5, pp. 2015-2024, 2008.
292. B. Sivaraman, K. P. Fears, and R.A. Latour, "Investigation of the effects of surface chemistry and solution concentration on the conformation of adsorbed proteins using an improved circular dichroism method, " Langmuir, vol. 25, no. 5, pp. 3050-3056, 2009.
293. J. Kim and G. A. Somorjai, "Molecular packing of lysozyme, fibrinogen, and bovine serum albumin on hydrophilic and hydrophobic surfaces studied by infrared-visible sumfrequency generation and fluorescence microscopy, " Journal of the American Chemical Society, vol. 125, no. 10, pp. 3150-3158, 2003.
294. L. M. Szott and T. A. Horbett, "Protein interactions with surfaces: cellular responses, complement activation, and newer methods, " Current Opinion in Chemical Biology, vol. 15, no. 5, pp. 677-682, 2011.
295. E. P. Vieira, S. Rocha, M. Carmo Pereira, H. Möhwald, and M. A. N. Coelho, "Adsorption and diffusion of plasma proteins on hydrophilic and hydrophobic surfaces: effect of trifluoroethanol on protein structure, " Langmuir, vol. 25, no. 17, pp. 9879-9886, 2009.
296. T. Betancourt and L. Brannon-Peppas, "Micro- and nanofabrication methods in nanotechnological medical and pharmaceutical devices, " International Journal of Nanomedicine, vol. 1, no. 4, pp. 483-495, 2006.
297. A. K. Refai, M. Textor, D. M. Brunette, and J. D. Waterfield, "Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines, " Journal of Biomedical Materials Research, Part A, vol. 70, no. 2, pp. 194-205, 2004.
298. W. A. Soskolne, S. Cohen, L. Sennerby, A. Wennerberg, and L. Shapira, "The effect of titanium surface roughness on the adhesion of monocytes and their secretion of TNF-α and PGE2, " Clinical Oral Implants Research, vol. 13, no. 1, pp. 86-93, 2002.
299. P. C. S. Bota, A.M.B. Collie, P. Puolakkainen et al., "Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro, " Journal of Biomedical Materials Research Part A, vol. 95, no. 2, pp. 649-657, 2010.
300. A. M. B. Collie, P. C. S. Bota, R. E. Johns, R. V. Maier, and P. S. Stayton, "Differential monocyte/macrophage interleukin- 1β production due to biomaterial topography requires the β2 integrin signaling pathway, " Journal of Biomedical Materials Research. Part A, vol. 96, no. 1, pp. 162-169, 2011.
301. M. Mohiuddin, H.-A. Pan, Y.-C. Hung, and G. S. Huang, "Control of growth and inflammatory response of macrophages and foam cells with nanotopography, " Nanoscale Research Letters, vol. 7, no. 1, article 394, 2012.
302. K. R. Kam, L. A. Walsh, S. M. Bock, J. D. Ollerenshaw, R. F. Ross, and T. A. Desai, "The effect of nanotopography on modulating protein adsorption and the fibrotic response, " Tissue Engineering Part A, vol. 20, no. 1-2, pp. 130-138, 2014.
303. D.-H. Kim, P. P. Provenzano, C. L. Smith, and A. Levchenko, "Matrix nanotopography as a regulator of cell function, " The Journal of Cell Biology, vol. 197, no. 3, pp. 351-360, 2012.
304. F. Rosso, A. Giordano, M. Barbarisi, and A. Barbarisi, "From cell-ECM interactions to tissue engineering, " Journal of Cellular Physiology, vol. 199, no. 2, pp. 174-180, 2004.
305. J. R. Gamboa, S. Mohandes, P. L. Tran, M. J. Slepian, and J.-Y. Yoon, "Linear fibroblast alignment on sinusoidal wave micropatterns, " Colloids and Surfaces B: Biointerfaces, vol. 104, pp. 318-325, 2013.
306. M. Hulander, A. Lundgren, L. Faxälv et al., "Gradients in surface nanotopography used to study platelet adhesion and activation, " Colloids and Surfaces B: Biointerfaces, vol. 110, pp. 261-269, 2013.
307. J. Fink, R. Fuhrmann, T. Scharnweber, and R. P. Franke, "Stimulation ofmonocytes and macrophages: possible influence of surface roughness, " Clinical Hemorheology and Microcirculation, vol. 39, no. 1-4, pp. 205-212, 2008.
308. V. Vogel and M. Sheetz, "Local force and geometry sensing regulate cell functions, " Nature Reviews Molecular Cell Biology, vol. 7, no. 4, pp. 265-275, 2006.
309. C. L. Gilchrist, D. S. Ruch, D. Little, and F. Guilak, "Micro-scale and meso-scale architectural cues cooperate and compete to direct aligned tissue formation, " Biomaterials, vol. 35, no. 38, pp. 10015-10024, 2014.
310. Q.-L. Ma, L.-Z. Zhao, R.-R. Liu et al., "Improved implant osseointegration of a nanostructured titaniumsurface viamediation of macrophage polarization, " Biomaterials, vol. 35, no. 37, pp. 9853-9867, 2014.
311. K. S. Tan, L. Qian, R. Rosado, P. M. Flood, and L. F. Cooper, "The role of titanium surface topography on J774A.1 macrophage inflammatory cytokines and nitric oxide production, " Biomaterials, vol. 27, no. 30, pp. 5170-5177, 2006.
312. E. K. F. Yim, R.M. Reano, S.W. Pang, A. F. Yee, C. S. Chen, and K. W. Leong, "Nanopattern-induced changes in morphology and motility of smooth muscle cells, " Biomaterials, vol. 26, no. 26, pp. 5405-5413, 2005.
313. J. M. Łopacińska, C. Grədinaru, R. Wierzbicki et al., "Cell motility, morphology, viability and proliferation in response to nanotopography on silicon black, " Nanoscale, vol. 4, no. 12, pp. 3739-3745, 2012.
314. R. A. Gittens, T. McLachlan, R. Olivares-Navarrete et al., "The effects of combined micron-/submicron-scale surface roughness and nanoscale features on cell proliferation and differentiation, " Biomaterials, vol. 32, no. 13, pp. 3395-3403, 2011.
315. L. R. Madden, D. J. Mortisen, E. M. Sussman et al., "Proangiogenic scaffolds as functional templates for cardiac tissue engineering, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 34, pp. 15211-15216, 2010.
316. M. Navarro, A. Michiardi, O. Castaño, and J. A. Planell, "Biomaterials in orthopaedics, " Journal of the Royal Society Interface, vol. 5, no. 27, pp. 1137-1158, 2008.
317. D. Muller, J.-T. Schantz, H. Chim, A. Bader, and M. Whiteman, "Vascular guidance: microstructural scaffold patterning for inductive neovascularization, " Stem Cells International, vol. 2011, Article ID 547247, 6 pages, 2011.
318. Q. L. Loh and C. Choong, "Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size, " Tissue Engineering Part B: Reviews, vol. 19, no. 6, pp. 485-502, 2013.
319. J. Matena, S. Petersen, M. Gieseke et al., "SLM produced porous titanium implant improvements for enhanced vascularization and osteoblast seeding, " International Journal of Molecular Sciences, vol. 16, no. 4, pp. 7478-7492, 2015.
320. A. Artel, H. Mehdizadeh, Y.-C. Chiu, E. M. Brey, and A. Cinar, "An agent-based model for the investigation of neovascularization within porous scaffolds, " Tissue Engineering Part A, vol. 17, no. 17-18, pp. 2133-2141, 2011.
321. Y. Kuboki, Q. Jin, and H. Takita, "Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis, " The Journal of Bone and Joint Surgery- American Volume, vol. 83, supplement 1, no. 2, pp. S105-S115, 2001.
322. H. J. Kim, U.-J. Kim, G. Vunjak-Novakovic, B.-H. Min, and D. L. Kaplan, "Influence ofmacroporous protein scaffolds on bone tissue engineering from bone marrow stem cells, " Biomaterials, vol. 26, no. 21, pp. 4442-4452, 2005.
323. M. Hulander, A. Lundgren, M. Berglin, M. Ohrlander, J. Lausmaa, and H. Elwing, "Immune complement activation is attenuated by surface nanotopography, " International Journal of Nanomedicine, vol. 6, pp. 2653-2666, 2011.
324. K. Rechendorff, M. B. Hovgaard, M. Foss, V. P. Zhdanov, and F. Besenbacher, "Enhancement of protein adsorption induced by surface roughness, " Langmuir, vol. 22, no. 26, pp. 10885-10888, 2006.
325. P. E. Scopelliti, A. Borgonovo, M. Indrieri et al., "The effect of surface nanometre-scale morphology on protein adsorption, " PLoS ONE, vol. 5, no. 7, Article ID e11862, 2010.
326. M. B. Hovgaard, K. Rechendorff, J. Chevallier, M. Foss, and F. Besenbacher, "Fibronectin adsorption on tantalum: the influence of nanoroughness, " Journal of Physical Chemistry B, vol. 112, no. 28, pp. 8241-8249, 2008.
327. A. Dolatshahi-Pirouz, T. Jensen, D. C. Kraft et al., "Fibronectin adsorption, cell adhesion, and proliferation on nanostructured tantalum surfaces, " ACS Nano, vol. 4, no. 5, pp. 2874-2882, 2010.
328. A. G. Harvey, E.W. Hill, and A. Bayat, "Designing implant surface topography for improved biocompatibility, " Expert Review of Medical Devices, vol. 10, no. 2, pp. 257-267, 2013.
329. W. Carver and E. C. Goldsmith, "Regulation of tissue fibrosis by the biomechanical environment, " BioMed Research International, vol. 2013, Article ID 101979, 10 pages, 2013.
330. P. G. Gillespie and R. G. Walker, "Molecular basis of mechanosensory transduction, " Nature, vol. 413, no. 6852, pp. 194-202, 2001.
331. A. J. Maniotis, C. S. Chen, and D. E. Ingber, "Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 3, pp. 849-854, 1997.
332. M. J. Dalby, "Topographically induced direct cell mechanotransduction, " Medical Engineering & Physics, vol. 27, no. 9, pp. 730-742, 2005.
333. M.-H. Kim, Y. Sawada, M. Taya, and M. Kino-oka, "Influence of surface topography on the human epithelial cell response to micropatterned substrates with convex and concave architectures, " Journal of Biological Engineering, vol. 8, no. 1, article 13, 2014.
334. L. E. McNamara, T. Sjöström, K. Seunarine, R. D. Meek, B. Su, and M. J. Dalby, "Investigation of the limits of nanoscale filopodial interactions, " Journal of Tissue Engineering, vol. 5, 2014.
335. M. J. Dalby, M. O. Riehle, D. S. Sutherland, H. Agheli, and A. S. G. Curtis, "Changes in fibroblast morphology in response to nano-columns produced by colloidal lithography, " Biomaterials, vol. 25, no. 23, pp. 5415-5422, 2004.
336. P. K. Mattila and P. Lappalainen, "Filopodia: molecular architecture and cellular functions, " Nature Reviews Molecular Cell Biology, vol. 9, no. 6, pp. 446-454, 2008.
337. B. J. Papenburg, E. D. Rodrigues, M. Wessling, and D. Stamatialis, "Insights into the role of material surface topography and wettability on cell-material interactions, " SoftMatter, vol. 6, no. 18, pp. 4377-4388, 2010.
338. D. W. Baker, X. Liu, H. Weng, C. Luo, and L. Tang, "Fibroblast/ fibrocyte: surface interaction dictates tissue reactions to micropillar implants, " Biomacromolecules, vol. 12, no. 4, pp.997-1005, 2011.
339. Z. Jahed, S. Molladavoodi, B. B. Seo, M. Gorbet, T. Y. Tsui, and M. R. K. Mofrad, "Cell responses to metallic nanostructure arrays with complex geometries, " Biomaterials, vol. 35, no. 34, pp. 9363-9371, 2014.
340. S. Vanni, H. Hirose, H. Barelli, B. Antonny, and R. Gautier, "A sub-nanometre view of how membrane curvature and composition modulate lipid packing and protein recruitment, " Nature Communications, vol. 5, article 4916, 2014.
341. B. Antonny, "Mechanisms of membrane curvature sensing, " Annual Review of Biochemistry, vol. 80, pp. 101-123, 2011.
342. H. T. McMahon and J. L. Gallop, "Membrane curvature and mechanisms of dynamic cell membrane remodelling, " Nature, vol. 438, no. 7068, pp. 590-596, 2005.
343. R. Muñoz-Planillo, P. Kuffa, G. Martínez-Colón, B. Smith, T. Rajendiran, and G. Núñez, "K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulatematter, " Immunity, vol. 38, no. 6, pp. 1142-1153, 2013.
344. L. Zhang, Z. Cao, T. Bai et al., "Zwitterionichydrogels implanted in mice resist the foreign-body reaction, " Nature Biotechnology, vol. 31, no. 6, pp. 553-556, 2013.
345. K. S. Jones, "Effects of biomaterial-induced inflammation on fibrosis and rejection, " Seminars in Immunology, vol. 20, no. 2, pp. 130-136, 2008.